Afatinib
Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
Imported from EML workbook.
Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
Formulations: - Oral > Solid: 10 mg capsule Indications: - Acute myeloid leukaemia with recurrent genetic abnormalities Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection Indications: - Plasma cell myeloma Source: EML workbook import
Formulations: - Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet Indications: - Chronic myeloid leukaemia, not elsewhere classified Source: EML workbook import
Formulations: - Oral > Solid: 100 mg; 150 mg Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
Formulations: - Oral > Solid > dispersible tablet: 2 mg; 3 mg; 5 mg Oral > Solid > tablet: 2.5 mg; 5 mg; 7.5 mg; 10 mg Indications: - Other specified gliomas of brain Source: EML workbook import
Indications: - Other specified malignant neoplasms of bronchus or lung Source: EML workbook import
Formulations: - Oral > Solid: 140 mg Indications: - Chronic lymphocytic leukaemia or small lymphocytic lymphoma Source: EML workbook import
Formulations: - Oral > Solid: 100 mg; 400 mg Indications: - B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 - Chronic myeloid leukaemia, not elsewhere classified - Gastrointestinal stromal tumour of unspecified gastrointestinal sites Source: EML workbook import
Formulations: - Oral > Solid > capsule: 150 mg; 200 mg Indications: - Chronic myeloid leukaemia, not elsewhere classified Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection Indications: - Carcinoma of breast, specialised type Source: EML workbook import
Formulations: - Oral > Solid: 80 mg Oral > Solid > capsule: 80 mg Indications: - Chronic lymphocytic leukaemia or small lymphocytic lymphoma Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.